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A B S T R A C T
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To assess the effects of mobile-based technologies versus standard practice for supporting communication and client management in
healthcare providers.
B A C K G R O U N D
Effective communication with other healthcare providers is essen-
tial for increasing health services capacity and providing optimal
care, especially in areas where there is a shortage of healthcare
providers (AAP 2015). The widespread use of information and
communication technologies can potentially expand the use of
telemedicine approaches to overcome networking gaps between
healthcare providers and increase the capacity of health services.
Description of the condition
By 2035, there will be a worldwide shortage of approximately 12.9
million skilled healthcare providers (Campbell 2013). The biggest
gaps occur in Southeast Asia and Sub-Saharan Africa, but else-
where too, ageing populations, rising prevalence of non-commu-
nicable diseases, migration patterns and high turnover of health-
care providers all contribute to a worldwide shortage of healthcare
providers in remote and rural areas, where populations are likely
to be poorer, sicker and less educated (OPHI 2017; Wu 2016).
Healthcare providers in those settings can be isolated and have
scarce interaction with colleagues and specialists, with few oppor-
tunities for mentoring, consultation with experts, or referrals to
other healthcare providers.
Description of the intervention
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Telemedicine is defined as the use of information and communi-
cation technologies for medical diagnostic, monitoring and thera-
peutic purposes, when participants are separated by distance and/
or time, with the ultimate goal of improving the health of indi-
viduals and communities (Hersh 2006). Although telemedicine
and telehealth have been conceptualised separately, with the latter
being a broader term that also encapsulates non-clinical activities
such as professional education, the terms are often used synony-
mously (Hersh 2006; WHO 2016). The definition for mobile
health (mHealth) has emerged more recently and refers to the use
of mobile telecommunication technologies for delivering health-
care (Steinhubi 2013).
The exchange of information can happen synchronously (when
interactions happen in real time) or asynchronously (when there
is a lag between the clinical information being transmitted and the
response) and through different channels, including videoconfer-
encing, mobile applications, and secure messaging (Kruse 2017;
WHO 2016). The most common examples of telemedicine ser-
vices are store and forward services, wheremedical data is transmit-
ted to a healthcare provider for offline assessment; remote mon-
itoring services, where a healthcare provider uses technologies to
monitor a person at a distance; and interactive services, where
there is real-time interaction between a person and their healthcare
provider (WHO 2012; WHO in press).
The World Health Organization (WHO) conducted a global sur-
vey on eHealth (WHO 2016), in which the terms telehealth and
telemedicine were used interchangeably. Results showed that 57%
of the 122 surveyed countries used telehealth as part of the national
eHealth policy or strategy, and 22% had a dedicated national tele-
health policy or strategy (WHO 2016). The most common ar-
eas were teleradiology, telepathology, remote patient monitoring
and teledermatology, all of which were in use in more than half
of the surveyed countries (WHO 2016). Of those, teleradiology
programmes were most established, whereas the other programme
types were mainly informal or at the pilot stage.
In a bid to maximise the coverage of healthcare services, decrease
the costs associated with providing healthcare and optimise the
shortage of healthcare professionals, governments and healthcare
agencies all over the world have been funding telehealth pro-
grammes in countries of all income brackets. Some examples in-
clude the Technology Enabled Care Services programme in Eng-
land (NHS Commissioning Assembly 2015), the Scottish Cen-
tre for Telehealth and Telecare (SCTT 2017), the Telehealth pilot
programmes in Australia (Australian Govt Dept of Health), the
telehealth services provided within the Medicare programme in
the USA (MedPAC 2016), the Asia eHealth Information Network
(AeHIN 20017), and the KwaZulu-Natal Experience in South
Africa (Mars 2012).
How the intervention might work
The use of telemedicine between healthcare providers for commu-
nication, consultations and client management might contribute
to developing professional skills and expertise, as well as optimis-
ing multidisciplinary communication (AAP 2015). This is par-
ticularly relevant for settings where there is a shortage of health-
care providers, for instance in low- and middle-income countries
and in rural and remote areas. By enabling healthcare providers
who are geographically separated to exchange clinical informa-
tion, telemedicine can improve their performance, as well as foster
the uniformity of clinical practice and facilitate universal health
coverage. Technological advances and better telecommunication
systems allow for broader and less expensive access to remotely
delivered healthcare, making the intervention more accessible.
Notwithstanding the possibilities, telemedicine applications have
been inconsistently implemented, with varying degrees of success
due to technological challenges, legal considerations, human and
cultural factors, and uncertainty around economic benefits and
cost-effectiveness (WHO 2011). A global eHealth survey from
2016 reported that lack of funding, infrastructure, prioritisation,
and legislation or regulations were the most common barriers to
implementing telehealth programmes (WHO 2016). Overcom-
ing these barriers requires the implementation of comprehensive
regulatory guidelines, driven both by governmental and profes-
sional medical organisations; legislation on confidentiality, privacy
and liability; and the involvement of all stakeholders in designing,
implementing and evaluating telemedicine applications, focusing
on the safety and the effectiveness of applications (Agboola 2016;
WHO 2011).
Why it is important to do this review
The rapid progress in information and communication technolo-
gies is accelerating the evolution of telemedicine. Despite its po-
tential and the exponential growth of telemedicine applications
in the last decades, there are still unanswered questions about its
effectiveness. The rationale for conducting this review is to assess
the effectiveness of mobile technologies as a method for health-
care providers to communicate, diagnose and manage clients. Al-
though these technologies are now ubiquitous, their rapid expan-
sion has not been accompanied by a close assessment of their im-
pact, which led the WHO to commission guidelines to inform
investments of digital health applications for strengthening health
systems. This review is one of a suite of six Cochrane Reviews
that will contribute to those guidelines. We aim to assess the ef-
fectiveness of telemedicine not only on communication between
healthcare providers, but also acceptability, satisfaction, resources
use and unintended consequences. Research into the latter has
been particularly neglected but can provide crucial information
for implementing successful telemedicine programmes.
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O B J E C T I V E S
To assess the effects of mobile-based technologies versus standard
practice for supporting communication and client management
in healthcare providers.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We will include randomised trials reported as full-text studies,
conference abstracts and unpublished data, irrespective of their
publication status and language of publication.
Types of participants
All types of healthcare providers (i.e. professionals, paraprofession-
als and lay health workers) providing client care through mobile-
based technologies. We will include studies targeting patients with
any condition, regardless of their location, setting, diagnoses, or
demographic factors such as age.We will not include studies where
the primary purpose is education or training.
Types of interventions
We will include trials comparing healthcare delivered through a
mobile device versus standard care, which we define as usual care
for the setting where the study took place, including face-to-face
exchanges and communication through other non-digital chan-
nels.
By mobile-based technologies for healthcare providers to commu-
nicate and manage clients, we mean healthcare providers who are
geographically separated using information and communication
technologies. We will focus exclusively on engagement where the
healthcare provider enquiry receives a response in real-time or as
immediate as clinically appropriate.
We will focus exclusively on clinical information that profes-
sionals can exchange over wireless and mobile technologies, mo-
bile phones of any kind (but not analogue landline telephones),
tablets, personal digital assistants and smartphones. Communica-
tion channels via mobile device can include text messaging, video
messaging, social media, voice calls, voice over Internet Protocol
(VoIP), and videoconferencing, through software such as Skype,
WhatsApp or Google Hangouts.
We will include:
• studies in which the healthcare provider uses telemedicine
to seek clinical guidance and support from other qualified
healthcare providers in order to deliver direct patient care. This
would include coordination of referrals and requests for expert
opinion and diagnosis;
• studies in which the provider(s) seeking guidance is at a
different location from the provider(s) offering guidance; and
• studies in which the provider(s) seeking guidance transmits
clinical information via a mobile device and the provider(s)
offering guidance responds on any device, including stationary
devices.
We will include studies assessing unspecified types of communica-
tion devices for transmitting the clinical information, since studies
often fail to report this detail.
We will include all health issues and will not restrict the content
of clinical health information exchanged. We will include studies
where the digital component of the intervention is delivered as part
of a wider package if we have judged it to be the core component
of the intervention.
We will exclude:
• pilot and feasibility studies (pilot study defined as “a version
of the main study that is run in miniature to test whether the
components of the main study can all work together” and
feasibility study as “pieces of research done before a main study”;
Arain 2010);
• studies that compare different technical specifications of
telecommunication technologies (e.g. different communication
channels, software, etc.);
• studies in which the use of telecommunications technology
is not directly linked to patient care;
• studies in which the primary purpose is education/training;
• studies assessing the accuracy of a portable medical device.
Types of outcome measures
Primary outcomes
1. Providers’ adherence to recommended practice, guidelines
or protocols (for example, providing the service at the
recommended time, referral as recommended, screening and
prioritising groups of clients as recommended).
2. Time between presentation and appropriate management.
Secondary outcomes
1. Clients’ health status and well-being, using validated
measures, such as the Notthingham Health Profile or the SF-36
(McDowell 2006).
2. Healthcare provider acceptance of and satisfaction with the
intervention; this will include both objective measures, such as
the number of dropouts not explained by other reasons, and self-
reported acceptability and satisfaction, measured with a validated
scale, such as the Physician Worklife Survey (Konrad 1999).
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3. Client acceptability and satisfaction; this will include both
objective measures, such as the number of dropouts not
explained by other reasons, and self-reported acceptability and
satisfaction, measured with a validated scale, such as the Patient
Satisfaction Scale (La Monica 1986).
4. Resource use, including cost to the user and cost to the
service (e.g. human resources/time, training, supplies and
equipment). This measure will need to be pre-specified and
available directly from the Results section.
5. Unintended consequences. These could include:
misreading or misinterpretation of data; transmission of
inaccurate data; loss of verbal and non-verbal communication
cues, including between provider and user; issues of privacy and
disclosure; affecting interpersonal relationships; negative impacts
on equity; failure or delay in the message delivery.
Search methods for identification of studies
Electronic searches
An information specialist developed the search strategies in con-
sultation with the review authors and WHO content experts. We
will use a minimum cutoff search date of 2000, based on the
increased availability and penetration of mobile devices used for
telemedicine from that date on (ITU 2017). Appendix 1 lists
the search strategy for MEDLINE. We will search the following
databases.
• Cochrane Central Register of Controlled Trials
(CENTRAL; latest issue), in the Cochrane Library.
• MEDLINE Ovid.
• Embase Ovid.
• POPLINE.
• WHO Global Health Library.
Searching other resources
Trial registries
We will search clinicaltrials.gov (clinicaltrials.gov) and the World
Health Organization International Clinical Trials Registry Plat-
form (who.int/ictrp).
Grey literature
We will also conduct a grey literature search to identify studies
not indexed in the databases listed above. We will search for rele-
vant systematic reviews and primary studies on similar topics using
Epistemonikos (epistemonikos.org), which is a database of health
evidence and a large source of health-related systematic reviews.
We will search all the contributed content in mHealthEvidence (
mhealthevidence.org), a database of global literature on mHealth.
We will contact authors of relevant studies/reviews to clarify re-
ported published information and to seek unpublished results/
data as well as researchers with expertise relevant to the review
topic.Moreover,WHOwill issue a call for papers through popular
digital health communities of practice such as the Global Digital
Health Network and Implementing Best Practices, to identify ad-
ditional primary studies as well as grey literature.
Data collection and analysis
Selection of studies
We will download all titles and abstracts retrieved by electronic
searching to a reference management database and remove dupli-
cates. For title and abstract screening, we will use a machine learn-
ing classifier that is able to assign a probability score that a given
record describes, or does not describe, a randomised trial (Wallace
2017). Two review authors (of BB, NH, NM) will screen titles
and abstracts of studies with at least a 10% probability of being
a randomised trial, and one review author will screen those with
less than a 10% probability. We will retrieve the full-text study
reports/publication of all potentially eligible reports, and two re-
view authors (of BB, NH, NM) will independently screen the full
text to identify studies for inclusion and to identify and record
reasons for excluding the ineligible studies. We will resolve any
disagreement through discussion, and if required we will consult
a third review author (DGB or SS).
We will list studies that initially appeared tomeet the inclusion cri-
teria but that we later excluded in the ’Characteristics of excluded
studies’ table. We will collate multiple reports of the same study so
that each study rather than each report is the unit of interest in the
review. We will also provide any information we can obtain about
ongoing studies. We will record the selection process in sufficient
detail to complete a PRISMA flow diagram (Liberati 2009).
Data extraction and management
We will use the EPOC standard data collection form and adapt
it for study characteristics and outcome data (EPOC 2017a); we
will pilot the form on at least one study in the review. Two review
authors (of BB,NH,NM)will independently extract the following
characteristics from the included studies.
1. Methods: study design, unit of allocation, location and
study setting, withdrawals.
2. Participants: number, mean age, age range, sex, inclusion
criteria, exclusion criteria, other relevant characteristics.
3. Interventions: function of the intervention (monitoring,
consultation, therapy), intervention components (including type
of technology and mode of delivery, frequency of data
transmission), comparison, fidelity assessment. For this review,
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we defined monitoring as the continuous evaluation of the
progress of symptoms or a condition over a period of time;
consultation as an exchange between the healthcare provider and
the client, where the provider discusses the client’s health status
and provides guidance, support, or information; and therapy as
the ongoing management and care of a client, to counteract a
disease or disorder.
4. Outcomes: main outcomes specified and collected, time
points reported.
5. Notes: funding for trial, ethical approval.
Two review authors (of BB, NH, NM) will independently extract
outcome data from included studies. We will contact authors of
included studies to seek missing data. We will note in the ’Char-
acteristics of included studies’ table if outcome data are reported
in an unusable way. We will resolve disagreements by consensus
or by involving a third review author (DGB or SS). We will group
the studies by health condition being targeted. We will create a
miscellaneous category for studies focusing on rare conditions and
single studies of a condition, for which we will extract basic study
information and descriptive data, but not outcome or risk of bias
data.
Assessment of risk of bias in included studies
Two review authors (of BB, NH, NM) will independently assess
risk of bias for each study using the criteria outlined in theCochrane
Handbook for Systematic Reviews of Interventions (Higgins 2017),
plus the guidance from the EPOC group (EPOC 2017b). We
will resolve any disagreement by discussion or by involving a third
review author (DGBor SS).Wewill assess the risk of bias according
to the following domains.
1. Random sequence generation.
2. Allocation concealment.
3. Blinding of participants and personnel.
4. Blinding of outcome assessment.
5. Incomplete outcome data.
6. Selective outcome reporting.
7. Baseline outcomes measurement.
8. Baseline characteristics.
9. Other bias.
We will judge the risk of each potential source of bias as being
high, low or unclear and provide a quotation from the study report
together with a justification for our judgment in the ’Risk of bias’
table.We will summarise the ’Risk of bias’ judgments across differ-
ent studies for each of the domains listed. We will consider blind-
ing separately for different key outcomes where necessary (e.g. for
unblinded outcome assessment, risk of bias for all-cause mortality
may be very different than for a patient-reported pain scale). We
will assess incomplete outcome data separately for different out-
comes. Where information on risk of bias relates to unpublished
data or correspondence with a trialist, we will note this in the ’Risk
of bias’ table. We will not exclude studies on the grounds of their
risk of bias but will clearly report the risk of bias when presenting
the results of the studies.
When considering treatment effects, we will take into account the
risk of bias for the studies that contribute to that outcome.
We will conduct the review according to this published protocol
and report any deviations form it in the ’Differences between pro-
tocol and review’ section of the systematic review.
Measures of treatment effect
We will estimate the effect of the intervention using risk ratios
and associated 95% confidence intervals for dichotomous data,
and standardised mean differences and 95% confidence intervals
for continuous data (Higgins 2011). We will ensure that readers
can interpret an increase in scores for continuous outcomes in the
same way for each outcome, explain the direction of effect, and
report where the directions were reversed if this were necessary.
Unit of analysis issues
We will control for unit of analysis errors by reanalysing results
after adjusting for clustering. If there is not enough information
to reanalyse the results, we will try to contact the study authors in
order to obtain the necessary data. If we are not able to access all
the data we will not report confidence intervals or P values (EPOC
2017c).
Dealing with missing data
We will contact investigators in order to verify key study char-
acteristics and obtain missing outcome data where possible (e.g.
when a study report is only available as an abstract). We will try
to compute missing summary data from other reported statistics.
Whenever it is not possible to obtain data, we will report the level
of missingness and consider how that might impact the certainty
of the evidence.
Assessment of heterogeneity
If we find a sufficient number of studies we will conduct a meta-
analysis. We will use the I² statistic to measure heterogeneity
among the trials in each analysis. If we identify substantial hetero-
geneity, we will explore it by pre-specified subgroup analysis.
Assessment of reporting biases
We will attempt to contact study authors, asking them to provide
missing outcome data. Where this is not possible, and we consider
that the missing data can introduce serious bias, we will explore
the impact of including such studies in the overall assessment of
results. If we are able to pool more than 10 trials, we will create
and examine a funnel plot to explore possible publication biases,
interpreting the results with caution (Sterne 2011).
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Data synthesis
We will undertake meta-analyses only where this is meaningful,
that is, if the treatments, participants, andunderlying clinical ques-
tion are similar enough for pooling to make sense (Borenstein
2009). A commonway that trialists indicate the presence of skewed
data is by reporting medians and interquartile ranges. When we
encounter this we will note that the data are skewed and consider
the implications. Where a single trial reports multiple trial arms,
we will include only the relevant arms. If two comparisons (e.g.
intervention A versus usual care and intervention B versus usual
care) must be entered into the same meta-analysis, we will halve
the control group to avoid double-counting.
Subgroup analysis and investigation of heterogeneity
We plan to carry out the following subgroup analyses.
1. Healthcare provider type (e.g. lay versus professional
healthcare provider). Lay health workers (LHW) often provide
healthcare in settings where healthcare resources are scarcer, for
example targeting epidemics in low- and middle-income
countries and the specific health needs of minority communities
in high-income countries (Lewin 2010). Because LHW have no
formal professional tertiary education, their knowledge and
beliefs might moderate the effects of the intervention (Akinlua
2016).
2. Type of communication channel (e.g. voice, SMS,
interactive voice response, image exchange). Different
communication channels might be used differently and serve
distinct purposes (Ventola 2014), as well as providing a more
comprehensive and realistic opportunity for communication.
3. Setting/income level (e.g. low-income versus high-income
settings). Traditionally, the quality of healthcare is lower in low-
and middle-income countries (Mills 2014), which might
increase heterogeneity and preempt the pooled analysis of studies
conducted in different settings.
We will use the following outcomes in subgroup analysis.
1. Providers’ adherence to recommended practice, guidelines
or protocols (for example, providing the service at the
recommended time, linkage to referrals as recommended).
2. Time between presentation and appropriate management.
3. Clients’ health status and well-being.
We will use the formal statistical techniques of Mantel-Haenszel
and regression to test for subgroup interactions (Mantel 1959).
Sensitivity analysis
We will perform sensitivity analyses defined a priori to assess the
robustness of our conclusions and explore the impact on effect
sizes. This will involve restricting the analysis to published studies
and to studies at low risk of bias.
Summary of findings table
Two review authors will independently assess the certainty of
the evidence (high, moderate, low, and very low) using the five
GRADE considerations (risk of bias, consistency of effect, im-
precision, indirectness, and publication bias) (Guyatt 2008). We
will use methods and recommendations described in the Cochrane
Handbook for Systematic Reviews of Interventions (Schünemann
2017) and the EPOCworksheets (EPOC2017d), using GRADE-
pro software (GRADEpro GDT). We will resolve disagreements
on certainty ratings by discussion and provide justification for de-
cisions to down- or upgrade the ratings using footnotes in the ta-
ble, making comments to aid readers’ understanding of the review
where necessary. We will use plain language statements to report
these findings in the review (EPOC 2017e).
We will create a ’Summary of findings’ table for the main inter-
vention comparison and include the following outcomes in order
to draw conclusions about the certainty of the evidence within the
text of the review: providers’ adherence to recommended practice,
guidelines or protocols; time between presentation and appropri-
ate management; clients’ healthcare status; provider acceptability
or satisfaction with the intervention; resource use; and unintended
consequences.
We will consider whether there is any additional outcome infor-
mation that we were not able to incorporate into meta-analyses,
note this in the comments and state if it supports or contradicts
the information from the meta-analyses. If it is not possible to
meta-analyse the data, we will summarise the results in the text.
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A P P E N D I C E S
Appendix 1. MEDLINE search strategy
Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations, Ovid MEDLINE(R) Daily and Ovid MEDLINE(R)
1 exp Health Personnel/
2 (((health or medical or healthcare) adj (personnel or worker* or auxiliar* or staff or professional*)) or doctor* or physician* or GP
or general practitioner? or family doctor or nurse* or midwi* or clinical officer* or pharmacist* or dentist* or ((birth or childbirth or
labor or labour) adj (attendant? or assistant?))).ti,ab,kw.
3 ((lay or voluntary or volunteer? or untrained or unlicensed or nonprofessional? or non professional?) adj5 (worker? or visitor? or
attendant? or aide or aides or support$ or person$ or helper? or carer? or caregiver? or care giver? or consultant? or assistant? or
staff )).ti,ab,kw.
4 (paraprofessional? or paramedic or paramedics or paramedical worker? or paramedical personnel or allied health personnel or allied
health worker? or support worker? or home health aide?).ti,ab,kw.
5 ((community or village? or lay) adj3 (health worker? or health care worker? or healthcare worker?)).ti,ab,kw.
6 (doula? or douladural? or barefoot doctor?).ti,ab,kw.
7 1 or 2 or 3 or 4 or 5 or 6
8 Cell Phones/
9 Smartphone/
10 MP3-Player/
11 Computers, Handheld/
12 ((cell* or mobile*) adj1 (phone* or telephone* or technolog* or device*)).ti,ab,kw.
13 (handheld or hand-held).ti,ab,kw.
14 (smartphone* or smart-phone* or cellphone* or mobiles).ti,ab,kw.
15 ((personal adj1 digital) or (PDA adj3 (device* or assistant*)) or MP3 player* or MP4 player*).ti,ab,kw.
16 (samsung or nokia).ti,ab,kw.
17 (windows adj3 (mobile* or phone*)).ti,ab,kw.
18 android.ti,ab,kw.
19 (ipad* or i-pad* or ipod* or i-pod* or iphone* or i-phone*).ti,ab,kw.
20 (tablet* adj3 (device* or computer*)).ti,ab,kw.
21 Telemedicine/
22 Videoconferencing/ or Webcasts as topic/
23 Text Messaging/
24 Telenursing/
25 (mhealth or m-health or “mobile health” or ehealth or e-health or “electronic health”).ti,ab,kw.
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26 (telemedicine or tele-medicine or telehealth or tele-health or telecare or tele-care or telenursing or tele-nursing or telepsychiatry or
tele-psychiatry or telemonitor* or tele-monitor* or teleconsult* or tele-consult* or telecounsel* or tele-counsel* or telecoach* or tele-
coach*).ti,ab,kw.
27 (videoconferenc* or video-conferenc* or webcast* or web-cast*).ti,ab,kw.
28 (((text* or short or voice or multimedia or multi-media or electronic or instant) adj1 messag*) or instant messenger).ti,ab,kw.
29 (texting or texted or texter* or ((sms or mms) adj (service* or messag*)) or interactive voice response* or IVR or voice call* or
callback* or voice over internet or VOIP).ti,ab,kw.
30 (Facebook or Twitter or Whatsapp* or Skyp* or YouTube or “You Tube” or Google Hangout*).ti,ab,kw.
31 Mobile Applications/
32 “mobile app*”.ti,ab,kw.
33 Social Media/
34 (social adj (media or network*)).ti,ab,kw.
35 Reminder Systems/
36 (remind* adj3 (text* or system* or messag*)).ti,ab,kw.
37 Electronic Mail/
38 (electronic mail* or email* or e-mail or webmail).ti,ab,kw.
39 Medical informatics/ or Medical informatics applications/
40 Nursing informatics/ or Public health informatics/
41 ((medical or clinical or health or healthcare or nurs*) adj3 informatics).ti,ab,kw.
42 Multimedia/
43 Hypermedia/
44 Blogging/
45 (multimedia or multi-media or hypermedia or hyper-media or blog* or vlog* or weblog* or web-log*).ti,ab,kw.
46 Interactive Tutorial/
47 Computer-Assisted Instruction/
48 ((interactive or computer-assisted) adj1 (tutor* or technolog* or learn* or instruct* or software or communication)).ti,ab,kw.
49 or/8-48
50 randomized controlled trial.pt.
51 controlled clinical trial.pt.
52 randomized.ab.
53 placebo.ab.
54 drug therapy.fs.
55 randomly.ab.
56 trial.ab.
57 groups.ab.
58 or/50-57
59 exp animals/ not humans.sh.
60 58 not 59
61 7 and 49 and 60
62 limit 61 to yr=“2000 -Current”
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